Home > Financial Ratios > LACTOSE (INDIA)

LACTOSE (INDIA)
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for LACTOSE (INDIA)
Please provide your vote to see the results

LACTOSE (INDIA) Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 66.33-5.7996.48-31.65-4.68

What is the latest Core EBITDA Growth ratio of LACTOSE (INDIA) ?

The latest Core EBITDA Growth ratio of LACTOSE (INDIA) is 66.33 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202466.33
Mar2023-5.79
Mar202296.48
Mar2021-31.65
Mar2020-4.68

How is Core EBITDA Growth of LACTOSE (INDIA) Trending?

Years Core EBITDA Growth % Change
Mar2024 66.33
Positive
Mar2023 -5.79
Negative
Mar2022 96.48
Positive
Mar2021 -31.65
Negative
Mar2020 -4.68 -

Other Financial Ratios of LACTOSE (INDIA)


Compare Core EBITDA Growth ratio of peers of LACTOSE (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LACTOSE (INDIA) ₹119.1 Cr -2.5% -10.5% -37.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


LACTOSE (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LACTOSE (INDIA)

-2.5%

-10.5%

-37.6%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses